MYCN and neuroblastoma: One of the common genetic alterations in NB is amplification of the MYCN oncogene (MYCN-A), which is associated with worse overall survival, increased metastasis, and a higher risk of disease than for patients with MYCN-not-amplified (MYCN-NA) tumors (2).